Invacare Corporation
IVC · NYSE
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $25 | $15 | $29 | $46 |
| - Cash | $66 | $59 | $45 | $44 |
| + Debt | $276 | $476 | $406 | $388 |
| Enterprise Value | $234 | $433 | $390 | $390 |
| Revenue | $165 | $181 | $170 | $189 |
| % Growth | -8.7% | 6.4% | -9.8% | – |
| Gross Profit | $44 | $48 | $31 | $48 |
| % Margin | 26.5% | 26.6% | 18.4% | 25.4% |
| EBITDA | -$10 | -$28 | -$24 | -$11 |
| % Margin | -6% | -15.2% | -14.1% | -5.6% |
| Net Income | -$41 | -$21 | -$34 | -$22 |
| % Margin | -24.9% | -11.3% | -20.2% | -11.6% |
| EPS Diluted | -1.08 | -0.56 | -0.91 | -0.61 |
| % Growth | -92.9% | 38.5% | -49.2% | – |
| Operating Cash Flow | -$31 | -$8 | -$20 | $1 |
| Capital Expenditures | -$2 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$33 | -$9 | -$20 | $0 |